Literature DB >> 11781390

Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress.

Jianguo Du1, Jing Luan, Hua Liu, Thomas O Daniel, Stephen Peiper, Theresa S Chen, Yingchun Yu, Linda W Horton, Lillian B Nanney, Robert M Strieter, Ann Richmond.   

Abstract

CXC chemokines, which induce angiogenesis, have glutamine-leucine-arginine amino acid residues (ELR motif) in the amino terminus and bind CXCR2 and the Duffy antigen chemokine-binding protein. Duffy, a seven transmembrane protein that binds CXC and CC chemokines, has not been shown to couple to trimeric G proteins or to transduce intracellular signals, although it is highly expressed on red blood cells, endothelial cells undergoing neovascularization, and neuronal cells. The binding of chemokines by Duffy could modulate chemokine responses positively or negatively. Positive regulation could come through the presentation of chemokine to functional receptors, and negative regulation could come through Duffy competition with functional chemokine receptors for chemokine binding, thus serving as a decoy receptor. To determine whether Duffy has a role in angiogenesis and/or maintenance of homeostasis, we developed transgenic mice expressing mDuffy under the control of the preproendothelin promoter/enhancer (PPEP), which directs expression of the transgene to the endothelium. Two PPEP-mDuffy-transgenic founders were identified, and expression of the transgene in the endothelium was verified by Northern blot, RT-PCR, and immunostaining of tissues. The phenotype of the mice carrying the transgene appeared normal by all visual parameters. However, careful comparison of transgenic and nontransgenic mice revealed two phenotypic differences: mDuffy-transgenic mice exhibited a diminished angiogenic response to MIP-2 in the corneal micropocket assay, and mDuffy-transgenic mice exhibited enhanced hepatocellular toxicity and necrosis as compared with nontransgenic littermates in response to overdose of acetaminophen (APAP; 400 mg/kg body weight). Morover, APAP treatment was lethal in 50% of the mDuffy-transgenic mice 24 h post challenge, and 100% of the nontransgenic littermates survived this treatment at the 24 h time point. Our data suggest that enhanced expression of mDuffy on endothelial cells can lead to impaired angiogenic response to chemokines and impaired maintenance of homeostasis in response to toxic stresses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781390      PMCID: PMC2665273     

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  38 in total

Review 1.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

2.  Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants.

Authors:  L H Miller; S J Mason; J A Dvorak; M H McGinniss; I K Rothman
Journal:  Science       Date:  1975-08-15       Impact factor: 47.728

3.  Expression of chemokine receptors by subsets of neurons in the central nervous system.

Authors:  R Horuk; A W Martin; Z Wang; L Schweitzer; A Gerassimides; H Guo; Z Lu; J Hesselgesser; H D Perez; J Kim; J Parker; T J Hadley; S C Peiper
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

4.  Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence.

Authors:  M E Lee; K D Bloch; J A Clifford; T Quertermous
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

5.  Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor.

Authors:  A Chaudhuri; V Zbrzezna; J Polyakova; A O Pogo; J Hesselgesser; R Horuk
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

6.  Transcriptional regulation of the endothelin-1 gene by TNF-alpha.

Authors:  P A Marsden; B M Brenner
Journal:  Am J Physiol       Date:  1992-04

7.  Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells.

Authors:  M E Lee; D H Temizer; J A Clifford; T Quertermous
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

8.  Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC).

Authors:  T C Dawson; A B Lentsch; Z Wang; J E Cowhig; A Rot; N Maeda; S C Peiper
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

9.  A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor.

Authors:  R Horuk; C E Chitnis; W C Darbonne; T J Colby; A Rybicki; T J Hadley; L H Miller
Journal:  Science       Date:  1993-08-27       Impact factor: 47.728

10.  Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite.

Authors:  A Chaudhuri; J Polyakova; V Zbrzezna; K Williams; S Gulati; A O Pogo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

View more
  25 in total

Review 1.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 2.  Chemokines as mediators of angiogenesis.

Authors:  Borna Mehrad; Michael P Keane; Robert M Strieter
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

Review 3.  Chemokines as mediators of tumor angiogenesis and neovascularization.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Exp Cell Res       Date:  2010-10-30       Impact factor: 3.905

Review 4.  Platelet-derived chemokines: pathophysiology and therapeutic aspects.

Authors:  Hans-Dieter Flad; Ernst Brandt
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

Review 5.  CXC chemokines in cancer angiogenesis and metastases.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

6.  Lung Angiogenesis Requires CD4(+) Forkhead Homeobox Protein-3(+) Regulatory T Cells.

Authors:  Franco R D'Alessio; Qiong Zhong; John Jenkins; Aigul Moldobaeva; Elizabeth M Wagner
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

Review 7.  Chemokines in health and disease.

Authors:  Dayanidhi Raman; Tammy Sobolik-Delmaire; Ann Richmond
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

Review 8.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

9.  DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines.

Authors:  Jörg Reutershan; Brian Harry; Daniel Chang; Gregory J Bagby; Klaus Ley
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

Review 10.  Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?

Authors:  Carlo Chizzolini; Jean-Michel Dayer; Pierre Miossec
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.